Relief Therapeutics Holding AG (RLFTF) Stock Makes an Interesting Move: Are You Excited?

This morning many investors are going to be looking into stocks that recorded...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

Coeptis Therapeutics Could Go To The Moon This Week!
Here is Who Just Picked Ptc Therapeutics Inc. (NASDA...
Salon Media Group, Inc. (OTCMKTS:SLNM) is Attracting...

This morning many investors are going to be looking into stocks that recorded considerable gains last week and by that token, it is likely that the Relief Therapeutics Holding AG (OTCMKTS:RLFTF) stock is going to be one of those. The stock recorded gains of 25.50% this past Friday and ended the week with cumulative gains of as much as 57%.

Hence, it might be a good idea to actually keep an eye on the Relief stock this morning. The rally in the stock was brought about by a press release from the company’s collaboration partner NRx Pharmaceuticals last week. In the press release, the company provided information about a key milestone regarding aviptadil, the product on which the two companies are working.

NRx revealed that a commercial formulation of aviptadil that could be put to intravenous use had been validated. That is a major development since the company will now start preparing for industrial-scale manufacturing of the product. It was also noted that the aviptadil that is going to be commercially manufactured will also have the stability of a year or more as long as it is stored in ideal conditions.

On the other hand, NRx has also managed to boost its manufacturing capacity and is in a position to boost the manufacturing lot size of aviptadil by 30 to 50 times. It was a major development and it was no surprise that the Relief Therapeutics stock moved in such a big way. It remains to be seen if the stock can continue to add to its gains today.

Stay in the lopp :

Healthier Choices Management (HCMC) Stock Sud...

Over the past week or so, the Healthier Choices Management Corp (OTCMKTS:HCMC) has been on the radars of many investors owing to the

VIGL Stock Price is so consistent, can it go ...

Vigil Neuroscience VIGL stock price is up -16% in the last 5 days & volume is up 66%, but is it

Kingstown Capital Partners is Buying Novelion...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Novelion Therapeutics Inc. (NASDAQ:NVLN) reported that Kingstown Capital Partners, Llc.

related post

Skip to content